Iterum Therapeutics plc — Director's Dealing 2021

Jun 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2021-06-23

Reporting Person: Ahrens Brenton Karl (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-23	Stock Option (Right to Buy)	$2.01	A	64706	Acquired	2031-06-22	Ordinary Shares (64706)	Direct

Footnotes

F1: Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 23, 2022.